40 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Melinta Therapeutics, Inc. MLNT shares climbed 143.4% to $4.82 after the company reported FDA approval of its BAXDELA sNDA for the treatment of community acquired bacterial pneumonia.
• Akerna Corp. KERN shares gained 63.5% to $25.11.
• Foresight Autonomous Holdings Ltd. FRSX shares climbed 52.1% to $1.43 after the company signed a commercial agreement with Elbit Systems for exclusive marketing of its software for the defense market.
• Arcturus Therapeutics Holdings Inc ARCT jumped 36.7% to $7.90 after the company expanded its research collaboration and licensing agreement with Ultragenyx to develop nucleic acid therapies. The company will receive upfront payments and an equity investment.
• Axalta Coating Systems Ltd. AXTA rose 14.5% to $29.58 after the company announced it has initiated a review of strategic alternatives to maximize shareholder value.
• Dyadic International, Inc. DYAI gained 12.2% to $7.25.
• MYOS Corporation MYOS rose 11.5% to $1.4940 after the company disclosed positive top-line results from a study evaluating the impact of Fortetropin on the rate of muscle protein synthesis in older men and women.
• Jabil Inc. JBL gained 10.1% to $30.07. Jabil reported in-line earnings for its third quarter, while sales exceeded estimates. The company also issued in-line Q4 guidance.
• Zynex, Inc. ZYXI rose 9.9% to $10.79.
• CannTrust Holdings Inc CTST gained 9.5% to $5.40 after the company announced Wednesday its entrance to the U.S. market, starting in the state of California.
• Nabors Industries Ltd. NBR shares rose 9% to $2.4404.
• Nabriva Therapeutics plc NBRV gained 8.6% to $2.28 after the company reported submission of FDA Type-A meeting request for intravenous CONTEPO.
• Arch Coal, Inc. ARCH gained 8% to $97.63 after the company announced it would combine with Peabody Energy for a joint venture.
• Vuzix Corporation VUZI surged 7.8% to $4.00.
• Veritone, Inc. VERI shares gained 7.5% to $8.85.
• Qudian Inc. QD shares rose 7.5% to $8.09.
• Akorn, Inc. AKRX gained 7.1% to $4.80.
• Ironwood Pharmaceuticals, Inc. IRWD shares jumped 7.1% to $12.31.
• United States Steel Corporation X shares rose 6.7% to $15.56. US Steel projects Q2 adjusted earnings of $0.40 per share and adjusted EBITDA of $250 million.
• La-Z-Boy Incorporated LZB rose 5.8% to $31.53 after the company reported Q4 EPS and sales results.
• Adobe Inc. ADBE rose 3.9% to $287.54 after the company reported better-than-expected Q2 EPS and sales results.

Check out these big penny stock gainers and losers

Losers

• Sesen Bio Inc SESN shares dropped 23.4% to $1.41. Sesen Bio priced its 20.41 million share offering at $1.47 per share.
• QuickLogic Corporation QUIK fell 26.2% to $0.5243 after the company announced the pricing of a 16 million share common stock offering at $0.50 per share, which will result in approximately $8 million in gross proceeds from the offering.
• Legacy Reserves Inc. LGCY dipped 22.1% to $0.0850 after the company filed for chapter 11 bankruptcy protection.
• Genocea Biosciences Inc GNCA shares fell 19.2% to $4.1350 after the company reported a 10 million shares common stock offering.
• MoneyGram International, Inc. MGI shares fell 15.6% to $3.2750 after climbing 167.59% on Tuesday.
• Calithera Biosciences, Inc. CALA fell 15.1% to $4.0261 after the company priced its 12.5 million share offering of common stock at $4.00 per share.
• Cherokee Inc CHKE fell 12.5% to $0.70 after the company reported worse-than-expected Q1 EPS and sales results.
• ContraVir Pharmaceuticals, Inc. CTRV shares fell 10.9% to $4.7220.
• Lonestar Resources US Inc. LONE dropped 10.8% to $2.64.
• Global Cord Blood Corporation CO shares declined 10.2% to $5.18 after the company reported worse-than-expected Q4 EPS and sales results.
• Spherix Incorporated SPEX dipped 9.6% to $2.44.
• Green Plains Inc. GPRE dropped 9.5% to $11.28. Green Plains announced plans to suspend quarterly dividend and priced offering of $105 million aggregate principal amount of 4.00% convertible senior notes due 2024.
• Zymeworks Inc. ZYME fell 9.2% to $18.31. Zymeworks filed prospectus supplements for offering of common shares and pre-funded warrants.
• Jaguar Health, Inc. JAGX dropped 8.2% to $5.16. Jaguar Health reported key finding for final canalevia technical section for proposed indication of chemotherapy-induced diarrhea in dogs.
• Sophiris Bio, Inc. SPHS fell 8.2% to $0.8900 after the company received EMA feedback on its Phase 3 prostate cancer trial design. The company expects data from a single phase 3 trial, if successful, will be sufficient to support marketing approval in Europe.
• The Lovesac Company LOVE fell 7.6% to $30.76.
• Cesca Therapeutics Inc. KOOL fell 5.6% to $2.9250 after rising 11.11% on Tuesday.
• Energizer Holdings, Inc. ENR fell 5.4% to $39.58. JP Morgan downgraded Energizer from Neutral to Underweight and lowered the price target from $45 to $36.
• YY Inc. YY fell 5.2% to $73.18 after the company reported a proposed offering of US$850 million convertible senior note.